Thursday, September 1, 2011
UTHealth Launches Study On New Depression Medication
A new medication to treat major depressive disorder in patients who have not responded to other antidepressants is being studied in a Phase II clinical trial by researchers at The University of Texas Health Science Center at Houston (UTHealth). The drug, identified as BMS-820836 by its maker Bristol-Myers Squibb, affects the brain's neurotransmitters serotonin and norepinephrine, said the study's principal investigator Jair Soares, M.D., professor and chair of the Department of Psychiatry and Behavioral Sciences at the UTHealth Medical School...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment